BioTuesdays

Author - Melane Sampson

BioNxt Solutions Logo

BioNxt achieves milestones for BNT23001 in MS

BioNxt Solutions (CSE:BNXT; OTC PINK:BNXTF; FSE:BXT) has announced that key milestones have been achieved in the development of BNT23001 for the treatment of multiple sclerosis (MS). BNT23001 is BioNxt’s proprietary...